[go: up one dir, main page]

NO20022973L - Oksazolidinoner som har en sulfoksiminfunksjonalitet - Google Patents

Oksazolidinoner som har en sulfoksiminfunksjonalitet

Info

Publication number
NO20022973L
NO20022973L NO20022973A NO20022973A NO20022973L NO 20022973 L NO20022973 L NO 20022973L NO 20022973 A NO20022973 A NO 20022973A NO 20022973 A NO20022973 A NO 20022973A NO 20022973 L NO20022973 L NO 20022973L
Authority
NO
Norway
Prior art keywords
oxazolidinones
sulfoximine
functionality
sulfoximine functionality
Prior art date
Application number
NO20022973A
Other languages
English (en)
Norwegian (no)
Other versions
NO20022973D0 (no
Inventor
Jr Jackson B Hester
David L Alexander
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of NO20022973D0 publication Critical patent/NO20022973D0/no
Publication of NO20022973L publication Critical patent/NO20022973L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20022973A 1999-12-21 2002-06-20 Oksazolidinoner som har en sulfoksiminfunksjonalitet NO20022973L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17191699P 1999-12-21 1999-12-21
PCT/US2000/032451 WO2001046185A1 (en) 1999-12-21 2000-12-12 Oxazolidinones having a sulfoximine functionality and their use as antimicrobial agents

Publications (2)

Publication Number Publication Date
NO20022973D0 NO20022973D0 (no) 2002-06-20
NO20022973L true NO20022973L (no) 2002-08-20

Family

ID=22625632

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022973A NO20022973L (no) 1999-12-21 2002-06-20 Oksazolidinoner som har en sulfoksiminfunksjonalitet

Country Status (22)

Country Link
US (1) US20010046987A1 (es)
EP (1) EP1242417A1 (es)
JP (1) JP2003518117A (es)
KR (1) KR20020067557A (es)
CN (1) CN1221548C (es)
AR (1) AR029211A1 (es)
AU (1) AU782078B2 (es)
BR (1) BR0016605A (es)
CA (1) CA2389482A1 (es)
CO (1) CO5251427A1 (es)
CZ (1) CZ20022142A3 (es)
EA (1) EA005567B1 (es)
HU (1) HUP0203869A2 (es)
IL (1) IL150348A0 (es)
MX (1) MXPA02006233A (es)
NO (1) NO20022973L (es)
NZ (1) NZ519725A (es)
PE (1) PE20010931A1 (es)
PL (1) PL356478A1 (es)
SK (1) SK7572002A3 (es)
WO (1) WO2001046185A1 (es)
ZA (1) ZA200204166B (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9928568D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
GB0009803D0 (en) 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
GB0108794D0 (en) * 2001-04-07 2001-05-30 Astrazeneca Ab Chemical compound
ES2268011T3 (es) * 2001-04-07 2007-03-16 Astrazeneca Ab Oxazolidinonas que contienen un grupo sulfonimida como antibioticos.
GB0108793D0 (en) * 2001-04-07 2001-05-30 Astrazeneca Ab Chemical compounds
GB0108764D0 (en) * 2001-04-07 2001-05-30 Astrazeneca Ab Chemical compounds
DE10129725A1 (de) 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
AR038536A1 (es) 2002-02-25 2005-01-19 Upjohn Co N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
US7141588B2 (en) 2002-02-25 2006-11-28 Pfizer, Inc. N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
TW200403240A (en) 2002-06-28 2004-03-01 Upjohn Co Difluorothioacetamides of oxazolidinones as antibacterial agents
US6875784B2 (en) 2002-10-09 2005-04-05 Pharmacia & Upjohn Company Antimibicrobial [3.1.0.] bicyclic oxazolidinone derivatives
DE10300111A1 (de) * 2003-01-07 2004-07-15 Bayer Healthcare Ag Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
CA2521685A1 (en) 2003-04-09 2004-10-21 Pharmacia & Upjohn Company Llc Antimicrobial [3.1.0] bicyclohexylphenyl-oxazolidinone derivatives and analogues
US7304050B2 (en) 2003-09-16 2007-12-04 Pfizer Inc. Antibacterial agents
US7265140B2 (en) * 2003-09-23 2007-09-04 Pfizer Inc Acyloxymethylcarbamate prodrugs of oxazolidinones
DE10355461A1 (de) 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
CA2589250A1 (en) * 2004-11-29 2006-06-01 Pharmacia & Upjohn Company Llc Diazepine oxazolidinones as antibacterial agents
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
EP1685841A1 (en) 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prevention and treatment of thromboembolic disorders
JP2008544979A (ja) 2005-06-29 2008-12-11 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 抗菌剤としてのホモモルホリンオキサゾリジノン
DE102005045518A1 (de) * 2005-09-23 2007-03-29 Bayer Healthcare Ag 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
EP1934208B1 (de) 2005-10-04 2011-03-23 Bayer Schering Pharma Aktiengesellschaft Neue polymorphe form von 5-chlor-n-({ ( 5s )-2-0x0-3-[4-( 3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl} -methyl)-2-thiophencarboxamid
DE102005047558A1 (de) * 2005-10-04 2008-02-07 Bayer Healthcare Ag Kombinationstherapie substituierter Oxazolidinone zur Prophylaxe und Behandlung von cerebralen Durchblutungsstörungen
DE102005047561A1 (de) 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
DE102007028319A1 (de) * 2007-06-20 2008-12-24 Bayer Healthcare Ag Substituierte Oxazolidinone und ihre Verwendung
WO2021184339A1 (en) * 2020-03-20 2021-09-23 Merck Sharp & Dohme Corp. Oxazolidinone compound and methods of use thereof as an antibacterial agent

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY115155A (en) * 1993-09-09 2003-04-30 Upjohn Co Substituted oxazine and thiazine oxazolidinone antimicrobials.
US5688792A (en) * 1994-08-16 1997-11-18 Pharmacia & Upjohn Company Substituted oxazine and thiazine oxazolidinone antimicrobials
US5952324A (en) * 1994-11-15 1999-09-14 Pharmacia & Upjohn Company Bicyclic oxazine and thiazine oxazolidinone antibacterials
CA2228647A1 (en) * 1995-09-01 1997-03-13 Pharmacia & Upjohn Company Phenyloxazolidinones having a c-c bond to 4-8 membered heterocyclic rings
CN1138765C (zh) * 1997-05-30 2004-02-18 法玛西雅厄普约翰美国公司 带有硫代羰基功能基的噁唑烷酮抗菌剂

Also Published As

Publication number Publication date
AR029211A1 (es) 2003-06-18
SK7572002A3 (en) 2002-12-03
IL150348A0 (en) 2002-12-01
CO5251427A1 (es) 2003-02-28
EA005567B1 (ru) 2005-04-28
CN1221548C (zh) 2005-10-05
AU2050201A (en) 2001-07-03
BR0016605A (pt) 2003-02-25
KR20020067557A (ko) 2002-08-22
NZ519725A (en) 2004-05-28
US20010046987A1 (en) 2001-11-29
MXPA02006233A (es) 2002-12-05
CN1391572A (zh) 2003-01-15
AU782078B2 (en) 2005-06-30
EA200200699A1 (ru) 2003-02-27
ZA200204166B (en) 2003-10-29
NO20022973D0 (no) 2002-06-20
WO2001046185A1 (en) 2001-06-28
CZ20022142A3 (cs) 2002-11-13
EP1242417A1 (en) 2002-09-25
JP2003518117A (ja) 2003-06-03
CA2389482A1 (en) 2001-06-28
PL356478A1 (en) 2004-06-28
PE20010931A1 (es) 2001-08-29
HUP0203869A2 (hu) 2003-07-28

Similar Documents

Publication Publication Date Title
NO20022973L (no) Oksazolidinoner som har en sulfoksiminfunksjonalitet
DE60314124D1 (de) 2-(2,6-dichlorphenyl)-diarylimidazole
ITMI20001803A0 (it) Dispensatore a doppia funzione
DE50007817D1 (de) Mikrospiegel
NO20051688D0 (no) Farmasoytiske blandinger som har en modifisert baerer
NO20015078L (no) Sulfonamidderivater som har oksadiazolringer
NO20000693D0 (no) Festeanordning
NO20041165L (no) Avstengningsanordning.
NO20030100L (no) Pleuromutilinderivater som har antibakteriell aktivitet
DK1026405T3 (da) Fastgørelsesanordning
BR0101990B1 (pt) dispositivo elÁstico de suspensço de uma estrutura vibratària em uma estrutura rÍgida.
IT1318923B1 (it) Pompa a doppia membrana - compatta
ITTO20030507A1 (it) Premistoppa a tenuta di fango.
DE60208495D1 (de) Kontrastphantom
IT1309591B1 (it) Composizioni a rilascio controllato di betaistina.
SE0202132L (sv) En jordbearbetningsenhet
DE60111415D1 (de) Nagelschneider
IT1317768B1 (it) Disposizione di azionamento con un dispositivo di regolazione.
DE502004004887D1 (de) Zangenaggregat einer kämmaschine
DE50004387D1 (de) Schliessvorrichtung
IT1318610B1 (it) Micomelanine a struttura polinaftoica.
DE59912578D1 (de) Turbomaschinenschaufel
IT1313589B1 (it) Composizioni a rilascio controllato di paracetamolo.
DK1380585T3 (da) Pyrazolopyridinon som mellemprodukt
ITMO990082A0 (it) Mezzi a gancio.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application